| Chapter 1 - Gastro-intestinal system |
| 1.1 - Chronic bowel disorders |
| 1.2 - Constipation and bowel cleansing |
| 1.3 - Diarrhoea |
| 1.6 - Gastric acid disorders and ulceration |
| 1.7 - Gastro-intestinal smooth muscle spasm |
| 1.9 – Obesity |
| 1.10 – Rectal and anal disorders |
| Chapter 2 - Cardiovascular System |
| 2.1 – Arrhythmias |
| 2.3 - Blood clots |
| 2.3.1 – Oral anticoagulants |
| 2.3.2 – Parenteral anticoagulants |
| 2.3.3 – Antiplatelet drugs |
| 2.1 Positive inotropic drugs |
| 2.2 Diuretics |
| 2.4 Beta-adrenoreceptor blocking drugs |
| 2.5 Drugs affecting the renin-angiotensin system |
| 2.5 Summary of Antihypertensive Drug Treatment |
| 2.5 Care Pathway for Hypertension |
| 2.5 Prescribing Guidelines for Heart Failure Guidance |
| 2.6 Nitrates, CCBs and potassium channel activators |
| 2.6 Primary Care Guidelines for drug treatment of Chronic Stable Angina Pectoris |
| 2.6.3 Other antianginal drugs |
| 2.6.4 Peripheral vasodilators and related drugs |
| 2.8 Anticoagulant drugs |
| 2.8.2 Drug Interactions for Apixaban, Dabigatran, Edoxaban and Rivaroxaban |
| 2.8.2 Decision aid for patients requiring stroke prevention in AF |
| 2.8.2 Reducing the risk of stroke in Atrial Fibrillation - NICE CG180 (including decision aid) |
| 2.8.2 NOAC Implementation priorities |
| 2.9 Antiplatelet drugs |
| 2.7 - Hyperlipidaemia |
| Chapter 3 - Respiratory System |
| 3 Introduction |
|
| Asthma Inhaler Pathways |
| Asthma Step-down Guides |
| Summary of recently introduced inhalers and their equivalents |
| 3.1 Bronchodilators |
| 3.2 Corticosteroids |
| 3.3.2 Leukotriene receptor antagonists |
| Guidance for managing COPD |
| 3.7 - Mucolytics |
| Chapter 4 - Central Nervous System |
| 4.1- Dementia |
| 4.2 - Epilepsy and other seizure disorders |
| 4.3 – Mental health disorders |
| 4.3.1 - Anxiety |
| 4.3.2 – Attention deficit hyperactivity disorder |
| 4.3.3 – Bipolar disorder and mania |
| 4.3.4 – Depression |
| 4.3.6 - Psychoses and schizophrenia |
| 4.4 - Movement disorders |
| 4.6 - Pain |
| 4.7 - Sleep disorders |
| 4.8 – Substance Dependence |
| Chapter 5 - Infections |
| Chapter 6 - Endocrine System |
| 6.1 – Antidiuretic hormone disorders |
| 6.2 - Bone metabolism disorders |
| 6.3 - Corticosteriod responsive conditions |
| 6.4 - Diabetes mellitus and hypoglycaemia |
| 6.4.1 - Blood glucose lowering drugs |
| 6.4.2 - Insulin |
| 6.4.3 - Blood glucose testing and continuous glucose monitoring (CGM) |
| 6.6 – Gonadotrophin responsive conditions |
| 6.8 – Sex hormone responsive conditions |
| 6.8.1 - Female sex hormone responsive conditions |
| 6.8.2 - Male sex hormone responsive conditions |
| 6.9 - Thyroid disorders |
| Chapter 7 – Genito-urinary system |
| 7.1 – Bladder and urinary disorders |
| 7.3 - Contraception |
| 7.4 – Erectile and ejaculatory conditions |
| 7.7 – Vaginal and vulval conditions |
| Chapter 8 - Immune system and malignant disease |
| 8.4 - Hormone responsive malignancy |
| Chapter 9 - Nutrition and Blood |
| 9.1 - Anaemias |
| 9.2 - Fluid and Electrolyte imbalances |
| 9.3 - Vitamin deficiency |
| Chapter 10 - Musculoskeletal system |
| 10.1 – Arthritis |
| 10.2 – Hyperuricaemia and gout |
| Chapter 11 – Eye |
| 11.1 - Allergic and inflammatory eye conditions |
| 11.2 – Dry eye conditions |
| 11.3 – Eye infections |
| 11.4 – Eye procedures |
| 11.5 – Glaucoma and ocular hypertension |
| Chapter 12 – Drugs acting on the Ear |
| 12.1 – Drugs acting on the Nose |
| 12.2 – Nasal Allergy |
| 12.3 – Drugs acting on the Oropharynx |
| Chapter 13 – Skin |
| 13.1 – Dry and scaling skin disorders |
| 13.2 – Infections of the skin |
| 13.3 – Inflammatory skin conditions |
| 13.5 - Pruritus |
| 13.6 – Rosacea and acne |
| 13.10 – Sun protection and photodamage |
| Chapter 15 & 16 - Anaesthesia and Emergency treatment of poisoning |
